Skip to content
The Policy VaultThe Policy Vault

pyrimethamineCareFirst (Caremark)

Primary prophylaxis of toxoplasmosis

Initial criteria

  • The requested drug is being prescribed for Pneumocystis jirovecii pneumonia prophylaxis OR primary prophylaxis of toxoplasmosis.
  • The patient has experienced an intolerance or has a contraindication to sulfamethoxazole/trimethoprim.
  • The patient has had a CD4 cell count less than 200 cells/mm3 within the past 3 months.

Approval duration

3 months